Swedish venture capital firm Healthcap specializes in investing in companies that try to find and develop medical solutions to serious diseases such as cancer and genetic diseases.
It's a strategy the firm has had for a long time, and the decision was recently made to expand the team and promote several new partners to advance the efforts.
Five people have boosted the senior team: four of them were promoted from other roles, and the new hire that started in September completes the quintet. Most importantly, Healthcap has promoted Mårten Steen to co-managing partner alongside founder Björn Odlander.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.Start a free company trial today
Your trial for MedWatch has now started
With your free trial you get:
Full access to all locked articles on MedWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.